Myelofibrosis

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Sponsored Video
Tim F and Dr Haddad
Sponsored Video
Myelofibrosis Caregiver Interview Series: Caregiver Input for Myelofibrosis Treatment Plans
06/08/2026
Fadi G. Haddad, MD
In the final installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD interviews Tim F., a caregiver from Pittsburgh, PA, about the critical role caregivers play in shared...
06/08/2026
Sponsored
Tim F.
Sponsored
Myelofibrosis Caregiver Interview Series: The Impact of Myelofibrosis on Caregivers
05/18/2026
Fadi G. Haddad, MD
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
05/18/2026
Sponsored
Fadi Haddad, MD
Sponsored
Myelofibrosis Caregiver Interview Series: Involving Patients and Caregivers in Myelofibrosis Treatment Plans
05/06/2026
Fadi G. Haddad, MD
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
05/06/2026

Interactive Features

Pop Quiz
Myelofibrosis
Pop Quiz
Which JAK Inhibitor Remains the Standard of Care in Myelofibrosis?
09/25/2025
Miranda Manier, BA
In an interview with Consultant360, Junaid Anwar, MD, a hematology-oncology fellow at UT Health Houston, reviewed the current evidence base for JAK inhibitors in myelofibrosis from a pooled analysis of five...
09/25/2025

Clinical Insights

Sponsored Video
Tim F and Dr Haddad
Sponsored Video
Myelofibrosis Caregiver Interview Series: Caregiver Input for Myelofibrosis Treatment Plans
06/08/2026
Fadi G. Haddad, MD
In the final installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD interviews Tim F., a caregiver from Pittsburgh, PA, about the critical role caregivers play in shared...
06/08/2026
Sponsored
Tim F.
Sponsored
Myelofibrosis Caregiver Interview Series: The Impact of Myelofibrosis on Caregivers
05/18/2026
Fadi G. Haddad, MD
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
05/18/2026
Sponsored
Fadi Haddad, MD
Sponsored
Myelofibrosis Caregiver Interview Series: Involving Patients and Caregivers in Myelofibrosis Treatment Plans
05/06/2026
Fadi G. Haddad, MD
In the next installment of the Myelofibrosis Caregiver Interview Series, Fadi Haddad, MD, emphasizes a patient- and caregiver-centered approach to treatment planning—highlighting how clinical decisions...
05/06/2026
Sponsored
Tim F. and Fadi Haddad, MD
Sponsored
Myelofibrosis Caregiver Interview Series: Monitoring Myelofibrosis Treatment Effectiveness
04/21/2026
Fadi G. Haddad, MD
Monitoring treatment response in myelofibrosis requires a balanced assessment of patient-reported symptoms, objective scoring tools, hematologic parameters, and spleen size. In part 1 of this Myelofibrosis...
04/21/2026
Expert Q&A
Brady L Stein, MD
Expert Q&A
How the ASH Clinical Practice Guidelines Aim to Improve Myelofibrosis Management
12/22/2025
Brady L. Stein, MD
At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
12/22/2025